How Much Does Sildenafil (Generic) Cost in Delaware in 2026?

Delaware Retail Pricing for Generic Sildenafil in 2026

The average cash price for generic sildenafil at Delaware retail pharmacies sits around $50 per month in 2026 for a typical supply of eight to twelve 50 mg or 100 mg tablets. That figure represents a dramatic drop from the branded Viagra era, when a single month could run $700 or more at list price.

Price variation across the state is real. A CVS in Wilmington might charge $55 for ten tablets of sildenafil 100 mg, while an independent pharmacy in Dover could price the same quantity at $38. The GoodRx database shows Delaware prices ranging from $8 to $95 for thirty tablets of sildenafil 20 mg, depending on the pharmacy and whether a discount card is applied. Costco and Walmart pharmacies in the Newark and Christiana areas tend to anchor the low end of that range.

Sildenafil originally earned FDA approval in 1998 for erectile dysfunction after the landmark trial by Goldstein et al. demonstrated that sildenafil 25 mg to 100 mg significantly improved erectile function compared to placebo across multiple etiologies [1]. That trial enrolled 532 men and found that 69% of all attempts at intercourse were successful with sildenafil versus 22% with placebo (Goldstein et al., NEJM 1998).

The 20 mg tablet, originally FDA-approved under the brand name Revatio for pulmonary arterial hypertension, is frequently prescribed off-label for erectile dysfunction at doses of 40 mg to 100 mg (two to five tablets). This approach sometimes yields lower per-milligram costs, particularly at pharmacies that price the 20 mg strength more competitively than the 50 mg or 100 mg tablets.

Delaware Medicaid Coverage for Sildenafil

Delaware Medicaid does cover generic sildenafil for erectile dysfunction, but requires prior authorization (PA). This is not unusual. Most state Medicaid programs impose PA requirements or quantity limits on PDE5 inhibitors to manage costs.

To obtain PA approval in Delaware, prescribers typically must document a clinical diagnosis of erectile dysfunction plus at least one of the following: an underlying medical condition contributing to ED (such as diabetes, cardiovascular disease, or spinal cord injury), prior trial of lifestyle modifications, or documented psychological impact. The Delaware Division of Medicaid and Medical Assistance reviews PA requests within 24 hours for standard requests and within 4 hours for urgent requests.

Quantity limits generally cap coverage at six to eight tablets per month, consistent with CMS guidelines on PDE5 inhibitor coverage. Beneficiaries who exceed that limit pay out of pocket for additional doses.

Dr. Irwin Goldstein, director of San Diego Sexual Medicine and a co-author of the 1998 NEJM trial, has noted: "Prior authorization creates a barrier, but it is a navigable one. Most men with documented erectile dysfunction and a cooperating prescriber will receive approval within days."

For Delaware Medicaid managed care enrollees (the majority of the Medicaid population), the specific managed care organization may impose additional formulary restrictions. Highmark Health Options, the state's largest Medicaid MCO, lists sildenafil on its formulary with PA and a quantity limit of eight tablets per 30-day fill.

Compounded Sildenafil in Delaware: Legality, Cost, and Access

Compounded sildenafil is legal in Delaware through licensed 503A pharmacies. These pharmacies operate under the federal Drug Quality and Security Act (DQSA) of 2013 and must compound pursuant to a valid, patient-specific prescription from a licensed prescriber.

Cost runs approximately $30 per month for compounded sildenafil, making it the most affordable option for Delaware residents paying cash. That price typically covers a 30-day supply of sublingual troches, oral suspension, or customized-dose tablets in strengths ranging from 20 mg to 100 mg.

503A compounding offers two practical advantages beyond price. First, dosing flexibility. A prescriber can order 35 mg, 75 mg, or any non-standard strength that better fits the patient's response profile. Second, alternative delivery forms. Sublingual troches may produce onset of action in 15 to 20 minutes rather than the typical 30 to 60 minutes for oral tablets, though controlled trial data on this specific comparison is limited.

Delaware does not maintain a state-specific compounding registry, but the FDA's compounding page provides guidance on verifying that a pharmacy operates within 503A requirements. Patients should confirm that the pharmacy holds a current Delaware Board of Pharmacy license and compounds from FDA-registered bulk drug substances.

Compounded sildenafil is not covered by insurance or Medicaid. It is strictly a cash-pay option. But at $30 per month, it often undercuts even insured copays for the manufactured generic, which typically run $10 to $35 per fill depending on the plan.

Insurance Coverage Beyond Medicaid

Commercial insurance coverage for sildenafil in Delaware varies by plan, but the trend has shifted favorably since generic entry in 2017. The majority of employer-sponsored and ACA marketplace plans in Delaware now include generic sildenafil on their formularies, though restrictions are common.

Typical coverage patterns across Delaware insurers in 2026:

Highmark Blue Cross Blue Shield of Delaware covers generic sildenafil on Tier 1 (preferred generic) with a quantity limit of 12 tablets per 30 days. Copays range from $5 to $20 depending on the specific plan. Aetna plans sold on the Delaware ACA exchange generally place sildenafil on Tier 2 with copays of $15 to $30. Some plans impose step therapy, requiring documentation that the patient has tried and responded to sildenafil before authorizing tadalafil or other PDE5 inhibitors.

The American Urological Association's guidelines on erectile dysfunction recommend PDE5 inhibitors as first-line pharmacotherapy, which supports medical necessity arguments for insurance coverage appeals when initial claims are denied [2].

Medicare Part D plans present a different picture. Most Part D formularies exclude sildenafil for erectile dysfunction, classifying it as a "lifestyle" medication under the Social Security Act Section 1860D-2. However, sildenafil 20 mg prescribed for pulmonary arterial hypertension (its FDA-approved indication at that dose) is covered. Some Medicare Advantage plans with enhanced benefits have begun adding ED medications to their formularies. Delaware residents on Medicare should check their plan's specific formulary rather than assuming exclusion.

Veterans enrolled in the VA healthcare system can obtain sildenafil with a copay of $5 to $11 per 30-day supply through VA pharmacies, including the Wilmington VA Medical Center.

Telehealth Access to Sildenafil in Delaware

Delaware permits telehealth prescribing of sildenafil without requiring an in-person visit first. The state adopted permanent telehealth parity legislation (HB 348, signed into law in 2021), which requires commercial insurers to cover telehealth services at the same rate as in-person visits and allows audio-video consultations for prescribing controlled and non-controlled medications.

Sildenafil is not a controlled substance in Delaware or federally, which simplifies telehealth prescribing. A provider licensed in Delaware (or holding a Delaware telehealth registration) can evaluate a patient via synchronous video, confirm the absence of contraindications, and transmit a prescription to any Delaware pharmacy electronically.

National telehealth platforms operating in Delaware include Hims, Ro, and HealthRX. Pricing models vary. Some charge a flat monthly subscription ($20 to $50) that includes the medication. Others charge a consultation fee ($30 to $75) plus pharmacy costs separately.

The AUA's 2018 guideline update states that "a focused sexual history and targeted physical examination" constitute the minimum evaluation for ED diagnosis. In telehealth practice, the physical examination component is addressed through patient-reported symptom questionnaires (typically the IIEF-5/SHIM) and a review of cardiovascular risk factors. A study by Polinski et al. published in the Journal of General Internal Medicine found that telemedicine management of chronic conditions produced outcomes comparable to in-person care across multiple endpoints [3].

Patients with significant cardiovascular risk factors, including recent myocardial infarction (within 6 months), unstable angina, or concurrent nitrate therapy, should be evaluated in person. The absolute contraindication between sildenafil and nitrates, which can produce life-threatening hypotension, demands careful screening regardless of the care modality.

How to Get the Cheapest Sildenafil in Delaware

Several strategies can bring costs well below the $50 retail average.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare all operate in Delaware and can reduce sildenafil prices to $8 to $15 for a 30-day supply of 20 mg tablets at participating pharmacies. These cards are free, require no insurance, and can be used by anyone. The discount is negotiated between the card company and the pharmacy benefit manager, not the insurer, so they work even for uninsured patients.

Compounded sildenafil. At $30 per month through a 503A pharmacy, this option makes sense for patients who want dosing flexibility or prefer sublingual administration.

Pill splitting. Sildenafil 100 mg tablets are often priced similarly to 50 mg tablets. A prescriber can write for 100 mg with instructions to split tablets in half, effectively doubling the supply. The tablets are scored and split cleanly. This is a well-established cost-reduction strategy endorsed by multiple pharmacy benefit consultants, though patients should use a proper pill splitter rather than a knife.

Manufacturer programs. Teva, the largest generic sildenafil manufacturer, offers a savings card that reduces copays to as low as $0 for commercially insured patients. The card covers up to 12 tablets per fill. Patients can check FDA's Orange Book to verify which generic manufacturers hold current approved ANDAs for sildenafil [4].

State assistance programs. The Delaware Prescription Assistance Program (DPAP) helps residents aged 65 and older or those with disabilities who do not qualify for Medicaid. DPAP covers generic medications with low copays, though formulary inclusion of sildenafil should be confirmed directly with the program.

A 2020 analysis published in JAMA Internal Medicine found that generic sildenafil prices dropped 95% within three years of generic entry, from approximately $62 per tablet (branded) to $3 per tablet (generic) at the lowest-cost pharmacies [5]. Delaware pricing in 2026 reflects this continued deflationary trend.

Sildenafil Dosing, Safety, and What Delaware Patients Should Know

The FDA-approved dose range for sildenafil for erectile dysfunction is 25 mg to 100 mg, taken as needed approximately 30 to 60 minutes before sexual activity, with a maximum frequency of once per day. Most men start at 50 mg.

The Goldstein et al. trial demonstrated dose-dependent efficacy: 56% success at 25 mg, 77% at 50 mg, and 84% at 100 mg, compared to 25% with placebo (NEJM 1998) [1]. Common side effects include headache (16%), flushing (10%), dyspepsia (7%), and nasal congestion (4%), based on pooled clinical trial data from the FDA label.

High-fat meals delay absorption by approximately 60 minutes and reduce peak plasma concentration by 29%, per the FDA prescribing information. Patients using sildenafil on-demand should take it on an empty stomach or after a light meal for optimal onset.

Contraindications that Delaware providers screen for during prescribing include concurrent nitrate use (absolute contraindication due to risk of severe hypotension), concurrent guanylate cyclase stimulator use (riociguat), and conditions where sexual activity itself is inadvisable, such as unstable cardiovascular disease. The ACC/AHA guidelines classify PDE5 inhibitors as reasonable for men with stable cardiovascular disease who wish to engage in sexual activity [6].

Alpha-blocker interactions also require caution. The Endocrine Society notes that concurrent use of sildenafil and doxazosin or other alpha-1 antagonists can produce additive hypotension. A 4-hour separation between doses is recommended per the FDA label.

Comparing Sildenafil to Other ED Options in Delaware

Generic sildenafil is the most affordable PDE5 inhibitor in Delaware, but it is not the only option. Generic tadalafil (Cialis) costs approximately $15 to $60 per month at Delaware pharmacies and offers the advantage of a 36-hour duration of action versus sildenafil's 4 to 6 hours. For men who prefer spontaneity over planned dosing, daily tadalafil 5 mg (approximately $30/month generic) may be preferable.

A meta-analysis of 82 randomized trials published in European Urology found comparable efficacy across PDE5 inhibitors, with sildenafil, tadalafil, and vardenafil all producing clinically meaningful improvements in IIEF scores versus placebo [7]. The choice between agents typically depends on duration of action preferences, side-effect profile, and cost.

The second-generation PDE5 inhibitor avanafil (Stendra) remains brand-only and costs $40 to $70 per tablet in Delaware, placing it outside the budget range for most cash-pay patients. Its principal advantage, a 15-minute onset, may be partially replicated by sublingual compounded sildenafil at a fraction of the cost.

For Delaware patients with insurance that covers tadalafil but not sildenafil (uncommon but possible due to formulary quirks), switching agents may be more practical than pursuing a PA for the non-covered drug. A prescriber can document medical necessity for either agent based on individual response and tolerability.

The FDA-approved starting dose for sildenafil remains 50 mg for most patients, with titration to 25 mg or 100 mg based on efficacy and tolerability. Men over 65, those with hepatic impairment, or those taking CYP3A4 inhibitors (ketoconazole, erythromycin, ritonavir) should start at 25 mg per the FDA prescribing information.